NEW YORK (Reuters) - A consortium comprising Elliott Investment Management, Patient Square Capital and Veritas Capital is nearing a deal to acquire Syneos Health Inc, a provider of clinical research to drug developers with a market value of $4 billion, people familiar with the matter said. | May. 09